Feasibility of VOICES Elder Abuse Intervention in Primary Care Setting (VOICES-PC Feasibility)
CompletedPhase 1Results postedLast updated 17 July 2023
What this trial tests
Phase 1 trial testing Virtual cOaching in making Informed Choices on Elder Mistreatment Self-Disclosure (VOICES) in Elder Abuse in 80 participants. Completed in 22 June 2022.
Timeline
17 December 2021
Primary endpoint 22 June 2022
22 June 2022
Quick facts
Lead sponsor
Yale University
Phase
Phase 1
Status
Completed
Study type
INTERVENTIONAL
Allocation
na
Design
single group
Masking
none
Primary purpose
prevention
Enrollment
80
Start date
17 December 2021
Primary completion
22 June 2022
Estimated completion
22 June 2022
Sites
1 location across United States
Drugs / interventions tested
Virtual cOaching in making Informed Choices on Elder Mistreatment Self-Disclosure (VOICES)
60 and older, any sex, with Elder Abuse. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
ParticipationPrimary· 5-10 minutes before VOICES intervention use.
Participation will be determined by the number of patients enrolled in VOICES. Successful enrollment of 80 older adults (N=80).
Group
Value
95% CI
Older Adults Approached for the Study
80
UsagePrimary· 5-10 minutes directly following VOICES intervention.
Usage will be determined by the number of patients enrolled in the study that complete the VOICES tool. Our target is to enroll 80 older adults (N=80).
Group
Value
95% CI
Older Adults Enrolled in the Study
80
AcceptabilitySecondary· 5-10 minutes directly following VOICES intervention use.
Participant satisfaction will be measured using post-use satisfaction survey. Responses will be measured via two 5-point Likert scales where generally higher values represent better outcomes:
Scale 1- Satisfaction: Where 1= "Very Dissatisfied", 2= "Dissatisfied", 3= "Neutral", 4= "Satisfied", and 5= "Very Satisfied".
Scale 2- Agreement: Where 1= "Strongly Disagree", 2= "Disagree", 3= "Neutral", 4= "Agree", and and 5= "Strongly Agree".
Level of confidentiality and privacy provided while using VOICES (Scale 1)
Group
Value
95% CI
Older Adults in Primary Care Setting
4.45
± 0.96
The time it took to complete using the VOICES tool (Scale 1)
Group
Value
95% CI
Older Adults in Primary Care Setting
4.67
± 0.69
Ability to complete VOICES on their own on the iPad, without staff assistance (Scale 1)
Group
Value
95% CI
Older Adults in Primary Care Setting
4.60
± 0.74
Time to complete the tool on the iPad was short (Scale 2)
Group
Value
95% CI
Older Adults in Primary Care Setting
4.42
± 0.82
Participant felt engaged in the tool throughout the process (Scale 2)
Group
Value
95% CI
Older Adults in Primary Care Setting
4.29
± 0.96
Audio and visual aids of the tool were helpful (Scale 2)
Group
Value
95% CI
Older Adults in Primary Care Setting
4.15
± 0.98
Participant felt fonts, size and colors of text in the tool were appropriate and readable (Scale 2)
Group
Value
95% CI
Older Adults in Primary Care Setting
4.64
± 0.72
Using this tool on the iPad was very easy (Scale 2)
Group
Value
95% CI
Older Adults in Primary Care Setting
4.71
± 0.66
DemandSecondary· 5-10 minutes directly following VOICES intervention use.
Demand will be assess through examining how likely will VOICES be used by patients. To do this, the size of target population of elder mistreatment (EM) victims in the Primary Care setting will be measured by the percent who screen positive for EM and the percent who receive the Brief Negotiation Interview (BNI) portion of VOICES. The BNI is a method designed to enhance identifying EM among older adults-- the process intends to encourage reflection of the user with their behaviors and whether they are willing to seek change by identifying with and reporting their abuse.
Participants who screened positive for suspicion of elder mistreatment
Group
Value
95% CI
Older Adults in Primary Care Setting
6
Participants who self-identified with elder mistreatment
Group
Value
95% CI
Older Adults in Primary Care Setting
3
Participants who self-reported elder mistreatment
Group
Value
95% CI
Older Adults in Primary Care Setting
3
Participants who received the Brief Negotiated Interview (BNI) pathway
Group
Value
95% CI
Older Adults in Primary Care Setting
4
PracticalitySecondary· Actual time duration is assessed during VOICES use by the computer program (the actual duration of the patient's time using VOICES). Estimation of completed time is completed 5-10 minutes directly following VOICES intervention use.
Practicality will be assessed by observing the ease of VOICES use by patients. To do this, a series of steps will be watched to determine the efficiency of implementation measured by the average time (1) to consent \& orient participants to the tool and (2) needed to complete VOICES documented by the Research Assistant; and (3) patients perceived time of VOICES as measured on post-survey. Each of these will be reported as part of the overall outcome.
Actual VOICES Duration
Group
Value
95% CI
Older Adults in Primary Care Setting
9.31
± 4.33
Actual Consent Duration
Group
Value
95% CI
Older Adults in Primary Care Setting
14.09
± 4.54
Participant estimated time to completion
Group
Value
95% CI
Older Adults in Primary Care Setting
18.38
± 11.55
Efficacy of the Brief Negotiation InterviewSecondary· Measure collected 5-10 minutes directly following VOICES intervention.
To look at how many patients changed their readiness to disclose after completing the Brief Negotiation Interview (BNI)
Group
Value
95% CI
Older Adults Who Accessed Brief Negotiation Interview (BNI)
1
AccuracySecondary· Measure collected up to directly following VOICES intervention to 1 week following VOICES intervention.
To understand the accuracy of the VOICES tool, a preliminary evaluation of the accuracy of VOICES as a screening tool in correctly classifying elder mistreatment (EM) cases that were referred to Adult Protective Services (APS). The percent correct classification will be reported.
Participants substantiated for elder mistreatment by the social worker
Group
Value
95% CI
Older Adults in Primary Care Setting
6
Participants referred to APS by the social worker
Group
Value
95% CI
Older Adults in Primary Care Setting
1
Cases referred to APS that were substantiated and opened
Group
Value
95% CI
Older Adults in Primary Care Setting
1
Sponsor's own description
To test an interactive intervention to screen for Elder Abuse and Mistreatment (EM) in the Primary Care (PC) setting to promote self-identification and self-disclosure of EM.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Other trials of Virtual cOaching in making Informed Choices on Elder Mistreatment Self-Disclosure (VOICES)
Trials testing the same drug.
NCT05216081 — Feasibility of Elder Mistreatment VOICES-CI Screening Tool
· NA
· completed
NCT03834870 — Virtual cOaching in Making Informed Choices on Elder Mistreatment Self-Disclosure (VOICES)
· EARLY_PHASE1
· completed
Other recruiting trials for Elder Abuse
Currently open trials in the same condition.
NCT05958654 — DETECT-RPC Universal EM Screening
· NA
· recruiting
NCT06039930 — Tele-PROTECT Therapy: Effectiveness, Empowerment, and Implementation
· NA
· recruiting
Other Yale University trials
Trials by the same sponsor.
NCT06900998 — Pilot Study: Effects of Nimodipine on Alcohol Drinking
· Phase 2
· not yet recruiting
NCT04910984 — Developing a Chatbot to Promote HIV Testing
· NA
· not yet recruiting
NCT07458087 — Accuracy of the Accuro 3S
· NA
· not yet recruiting
NCT07398404 — A Multiple Health Behavior Change (MHBC) Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Pa
· Phase 1, PHASE2
· not yet recruiting
NCT07305324 — Improving Liver Fibrosis Diagnosis in Primary Care Using FibroX AI
· NA
· not yet recruiting
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Yale University
Last refreshed: 17 July 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05224843.